Life Science REIT puts itself up for sale as part of ‘strategic review’
Board exploring various optionsIn talks with potential buyersDividend axed after leasing delayIn news which caught most but maybe not all investors by surprise, Life Science REIT (LABS), which rents space to biotech and medtech companies, announced it was starting a strategic review 'to explore all strategic options available to maximise value for shareholders, which may include a potential...